| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6193264 | Journal of Thoracic Oncology | 2015 | 9 Pages |
Abstract
Models describing tumor dynamics and survival of advanced NSCLC patients first-treated with erlotinib were developed. The impacts of different covariates were quantified.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ahmed Abbas MSc, Sebastian MD, Matthias MD, Thomas MD, Deniz MD, Carsten MD, Jürgen MD, Lucia MD, Uwe MD,